Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Ellner

Showing results (201-210 of 228) with videos related to

Pageof 23
Sort By:
Clinical and Experimental Immunology|February 24, 2001
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patientsZ Toossi, H Mayanja-Kizza, C S Hirsch, et al.
Medicine|May 1, 1986
Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literatureM Wieland, M M Lederman, C Kline-King, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the communityS K Schwander, M Torres, C Carranza C, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1997
HIV-1 risk and vaccine acceptability in the Ugandan militaryD L Hom, J L Johnson, P Mugyenyi, et al.
Infection and Immunity|May 1, 1994
Inhibition of growth Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorI M Orme, S K Furney, P S Skinner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 5, 1998
Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research CollaborationJ L Johnson, M J Vjecha, A Okwera, et al.
The Journal of Infectious Diseases|September 1, 1993
Tuberculosis symposium: emerging problems and promiseJ J Ellner, A R Hinman, S W Dooley, et al.
Infection and Immunity|January 1, 1993
Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorI M Orme, S K Furney, P S Skinner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 24, 1998
Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosisJ L Johnson, A Okwera, M J Vjecha, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trialsR S Wallis, M Phillips, J L Johnson, et al.
Pageof 23

Showing results (201-210 of 228) with videos related to

Sort By:
Pageof 23
Clinical and Experimental Immunology|February 24, 2001
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patientsZ Toossi, H Mayanja-Kizza, C S Hirsch, et al.
Medicine|May 1, 1986
Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literatureM Wieland, M M Lederman, C Kline-King, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the communityS K Schwander, M Torres, C Carranza C, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1997
HIV-1 risk and vaccine acceptability in the Ugandan militaryD L Hom, J L Johnson, P Mugyenyi, et al.
Infection and Immunity|May 1, 1994
Inhibition of growth Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorI M Orme, S K Furney, P S Skinner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 5, 1998
Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research CollaborationJ L Johnson, M J Vjecha, A Okwera, et al.
The Journal of Infectious Diseases|September 1, 1993
Tuberculosis symposium: emerging problems and promiseJ J Ellner, A R Hinman, S W Dooley, et al.
Infection and Immunity|January 1, 1993
Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorI M Orme, S K Furney, P S Skinner, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 24, 1998
Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosisJ L Johnson, A Okwera, M J Vjecha, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trialsR S Wallis, M Phillips, J L Johnson, et al.
Pageof 23